Clinical Review Criteria — Sinus Surgeries (FESS, Sinuplasty, Septoplasty) and Propel® steroid nasal stent
Clinical review criteria governing medical necessity determinations for Functional Endoscopic Sinus Surgery (FESS), balloon sinuplasty, septoplasty (with/without turbinate procedures), and coverage for the Propel® drug-eluting steroid nasal stent for Kaiser Permanente Washington members.
MPC approved to adopt new criteria Functional Endoscopic Sinus Surgery (FESS), MCG A-0185 and Sinuplasty, MCG A-0478; requires 60-day notice, effective February 1, 2024.
MPC approved new hybrid Septoplasty criteria, KP-0812 12012025; 60-day notice required, effective 12/01/2025.
Moved Propel code from Medically necessary services policy to Sinus surgery policy and adopted medical necessity criteria for Propel; effective April 1, 2026.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.